Regeneron Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors

Shift Technologies Inc

Change company Symbol lookup

Select an option...

SFT Shift Technologies Inc

KMB Kimberly-Clark Corp

NURO NeuroMetrix Inc

OTTW Ottawa Savings Bancorp Inc

HMC Honda Motor Co Ltd

PAVMZ PAVmed Series Z Equity Warrants Exp 30 Apr 2024 *W EXP 04/30/2024

FFBW Ffbw Inc

CIB Bancolombia SA

TARA Protara Therapeutics Inc

SLAMU Slam Corp

Consumer Discretionary : Specialty Retail | Small Cap Blend

Company profile

Shift Technologies, Inc. is an end-to-end e-commerce platform transforming the used car industry with a technology-driven customer experience. Its segments include Retail and Wholesale. The Retail segment represents retail sales of used vehicles through the Company's e-commerce platform and fees earned on sales of value-added products associated with those vehicles sales, such as vehicle service contracts, guaranteed asset protection waiver coverage, prepaid maintenance plans, and appearance protection plans. The Wholesale segment represents sales of used vehicles through wholesale auctions or directly to a wholesaler (DTW). It provides technology-driven solutions throughout the car ownership lifecycle. It operates approximately nine vehicle inventory inspection, reconditioning and storage centers, with six spanning the West Coast from San Diego to Seattle and three new facilities in Austin, San Antonio and Dallas, Texas. It conducts its business through its wholly owned subsidiaries.

Regeneron Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors

5:18 pm ET April 26, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Regeneron Pharmaceuticals Inc. (REGN) slipped 2.25% to $674.82 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 2.81% to 4,175.20 and Dow Jones Industrial Average falling 2.38% to 33,240.18. Regeneron Pharmaceuticals Inc. closed $72.60 below its 52-week high ($747.42), which the company reached on April 8th.

The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) fell 0.72% to $184.68, Novartis AG ADR (NOVN.EB) fell 1.64% to $88.96, and Amgen Inc. (AMGN) fell 0.91% to $249.87. Trading volume (537,952) remained 118,076 below its 50-day average volume of 656,028.

Data source: Dow Jones Market Data, FactSet. Data compiled April 26, 2022.

-MarketWatch Automation

(END) Dow Jones Newswires

April 26, 2022 17:18 ET (21:18 GMT)